Revolution Medicines (RVMD) AI Analysis
Score
AI Score 35. Revolution Medicines, Inc. has a high price of $199.7 with a market cap of $42.8 billion, but it is in the clinical development stage with significant negative margins, including a net profit margin of -9.5%